Home Compliance DOJ Reaches Settlement with OraPharma, Inc., Pushing Novel AKS Theory ComplianceExpert OpinionFCANews DOJ Reaches Settlement with OraPharma, Inc., Pushing Novel AKS Theory March 1, 2023 31 Share FacebookLinkedinTwitter Mr.Music | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance CFIUS Proposes Important Changes to Foreign Investment Rules with Focus on Enforcement Compliance Start Here: Cyber Fundamentals for Public Policy Makers Episodes 4-6 Compliance Second Circuit Defines “Willfulness” Standard Under Anti-Kickback Statute